Phathom Pharmaceuticals, Inc. (PHAT) Tops Q1 EPS by 4c
Tweet
Share
E-mail
Get Alerts PHAT Hot Sheet
Join SI Premium – FREE
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) reported Q1 EPS of ($1.07), $0.04 better than the analyst estimate of ($1.11). Revenue for the quarter came in at $28.5 million versus the consensus estimate of $27.75 million.
For earnings history and earnings-related data on Phathom Pharmaceuticals, Inc. (PHAT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Robinhood Ventures Fund II opens at $22.50, IPO at $25
- Ideal Power (IPWR) Tops Q2 EPS by 2c
- MeiraGTx Holdings plc (MGTX) Tops Q2 EPS by 202c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
